SCHEMBL25063464

SCHEMBL25063464

Cc1cc(NC(C)C)ccc1C(=O)Nc1ncc(N=O)s1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 9/20 0.43
▸ ADORA2A P29274 2/20 0.41
▸ STAT3 P40763 3/20 0.38
▸ LCK P06239 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CDK2 P24941 2/20 0.37
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ MAPK13 O15264 1/20 0.36
▸ MAPK12 P53778 1/20 0.36
▸ MAPK11 Q15759 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK5 Q00535 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24072763 0.87 ADORA2A (0.43) ADORA2ASTAT3ALDH1A1NPC1MITF
SCHEMBL24072759 0.84 CDK2 (0.40) STAT3ALDH1A1NPC1MITFLMNA
SCHEMBL24072268 0.84 MAPK14 (0.47) MAPK14ADORA2ASTAT3LCKALDH1A1
SCHEMBL24072749 0.81 STAT3 (0.41) STAT3ALDH1A1NPC1MITFLMNA
SCHEMBL24072715 0.81 TRPV1 (0.45) STAT3ALDH1A1NPC1MITFLMNA
SCHEMBL27136866 0.81 PLK1 (0.41) MAPK14ADORA2ASTAT3LCKALDH1A1
SCHEMBL25063046 0.81 STAT3 (0.62) ADORA2ASTAT3ALDH1A1NPC1LMNA
SCHEMBL24072769 0.80 POLQ (0.41) ADORA2ASTAT3ALDH1A1NPC1MITF
SCHEMBL27134412 0.79 CCNE1 (0.44) MAPK14ADORA2ASTAT3ALDH1A1NPC1
SCHEMBL24072717 0.79 KDR (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2024-02-29 — — US disclosed
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066136-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MAPK14 3714/4885ADORA2A 2820/4885STAT3 3224/4885
US-20230057177-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, MDM2 MAPK14 3714/4885ADORA2A 2820/4885STAT3 3224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback